Cystatin C in critically ill patients treated with continuous venovenous hemofiltration

Hemodialysis International

Volumn 10, Issue SUPPL. 2, 2006, Pages

  Baas, Marije C ^a   Bouman, Catherine S C ^a   Hoek, Frans J ^a   Krediet, Raymond T ^a   Schultz, Marcus J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Acute renal failure; Clearance; Critically ill; CVVH; Cystatin C

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; CYSTATIN C; HEPARIN; HEPARIN LEO;

ACUTE KIDNEY FAILURE; ADULT; BLOOD SAMPLING; CLEARANCE; CLINICAL ARTICLE; CONFERENCE PAPER; CONSTANTS AND COEFFICIENTS; CONTINUOUS HEMOFILTRATION; CRITICAL ILLNESS; FEMALE; HUMAN; KIDNEY FUNCTION; MALE; OLIGURIA; PATIENT MONITORING; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; ULTRAFILTRATION;

ACUTE KIDNEY INJURY; BIOLOGICAL MARKERS; CRITICAL ILLNESS; CYSTATIN C; CYSTATINS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEMOFILTRATION; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PROTEASE INHIBITORS; TREATMENT OUTCOME;

EID: 33749345308     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2006.00115.x     Document Type: Conference Paper

References (23)

1. Block CA, Manning HL. Prevention of acute renal failure in the critically ill (review). Am J Respir Crit Care Med. 2002; 165: 320-324.
2. Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez-Bru C, Grubb A. Cystatin C as a marker of GFR-history, indications, and future research. Clin Biochem. 2005; 38: 1-8.
3. Tenstad O, Roald AB, Grubb A, Aukland K. Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest. 1996; 56: 409-414.
4. Vinge E, Lindergard B, Nilsson-Ehle P, Grubb A. Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest. 1999; 59: 587-592.
5. Donadio C, Lucchesi A, Ardini M, Giordani R. Cystatin C, beta 2-microglobulin, and retinol-binding protein as indicators of glomerular filtration rate: Comparison with plasma creatinine. J Pharm Biomed Anal. 2001; 24: 835-842.
6. Price CP, Finney H. Developments in the assessment of glomerular filtration rate (review). Clin Chim Acta. 2000; 297: 55-66.
7. Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function - a review. Clin Chem Lab Med. 1999; 37: 389-395.
8. Harmoinen AP, Kouri TT, Wirta OR, et al. Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes. Clin Nephrol. 1999; 52: 363-370.
9. Coll E, Botey A, Alvarez L, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000; 36: 29-34.
10. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis. 2002; 40: 221-226.
11. Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant. 2003; 18: 2024-2031.
12. Campo A, Lanfranco G, Gramaglia L, Goia F, Cottino R, Giusto V. Could plasma cystatin C be useful as a marker of hemodialysis low molecular weight proteins removal? Nephron Clin Pract. 2004; 98: C79-c82.
13. Balik M, Jabor A, Waldauf P, et al. Cystatin C as a marker of residual renal function during continuous hemodiafiltration. Kidney Blood Press Res. 2005; 28: 14-19.
14. Bellomo R, Ronco C. Continuous renal replacement therapy: Continuous blood purification in the intensive care unit. Ann Acad Med Singapore. 1998; 27: 426-429.
15. Bouman C, Kan H, Schultz M, Vroom M. The removal of antibiotics during continuous venovenous hemofiltration (CVVH) in critically ill patients with acute renal failure: Measured versus estimated CVVH clearance (abstract). Crit Care. 2005; 9.
16. Sjostrom P, Tidman M, Jones I. Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans. Scand J Clin Lab Invest. 2005; 65: 111-124.
17. den Hollander JG, Wulkan RW, Mantel MJ, Berghout A. Is cystatin C a marker of glomerular filtration rate in thyroid dysfunction? Clin Chem. 2003; 49: 1558-1559.
18. Fricker M, Wiesli P, Brandle M, Schwegler B, Schmid C. Impact of thyroid dysfunction on serum cystatin C. Kidney Int. 2003; 63: 1944-1947.
19. Bjarnadottir M, Grubb A, Olafsson I. Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells. Scand J Clin Lab Invest. 1995; 55: 617-623.
20. Cimerman N, Brguljan PM, Krasovec M, Suskovic S, Kos J. Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients. Clin Chim Acta. 2000; 300: 83-95.
21. Poge U, Gerhardt T, Bokenkamp A, et al. Time course of low molecular weight proteins in the early kidney transplantation period-influence of corticosteroids. Nephrol Dial Transplant. 2004; 19: 2858-2863.
22. Mariano F, Fonsato V, Lanfranco G, et al. Tailoring high-cut-off membranes and feasible application in sepsis-associated acute renal failure: In vitro studies. Nephrol Dial Transplant. 2005; 20: 1116-1126.
23. Bouman CS, van Olden RW, Stoutenbeek CP. Cytokine filtration and adsorption during pre- and postdilution hemofiltration in four different membranes. Blood Purif. 1998; 16: 261-268.